New sleep disorder drug tested for Long-Term safety and effectiveness

NCT ID NCT06767683

Recruiting now Disease control Sponsor: Alkermes, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 31 times

Summary

This study looks at the long-term safety and how well the drug ALKS 2680 works for people with narcolepsy type 1, type 2, or idiopathic hypersomnia. It is for those who have already finished a related earlier study. Participants will take ALKS 2680 tablets and be monitored for side effects and changes in sleepiness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Alkermes Investigational Site
RECRUITING

Little Rock, Arkansas, 72211, United States
Alkermes Investigational Site
RECRUITING

Los Angeles, California, 90025, United States
Alkermes Investigational Site
RECRUITING

Stanford, California, 94305, United States
Alkermes Investigational Site
RECRUITING

Colorado Springs, Colorado, 80918, United States
Alkermes Investigational Site
RECRUITING

Brandon, Florida, 33511, United States
Alkermes Investigational Site
RECRUITING

Miami, Florida, 33176, United States
Alkermes Investigational Site
RECRUITING

Winter Park, Florida, 32789, United States
Alkermes Investigational Site
RECRUITING

Atlanta, Georgia, 30328, United States
Alkermes Investigational Site
RECRUITING

Macon, Georgia, 31210, United States
Alkermes Investigational Site
RECRUITING

Stockbridge, Georgia, 30281, United States
Alkermes Investigational Site
RECRUITING

Peoria, Illinois, 61637, United States
Alkermes Investigational Site
RECRUITING

Lansing, Michigan, 48911, United States
Alkermes Investigational Site
RECRUITING

Sterling Heights, Michigan, 48314, United States
Alkermes Investigational Site
RECRUITING

Lincoln, Nebraska, 68506, United States
Alkermes Investigational Site
RECRUITING

Middletown, New Jersey, 07748, United States
Alkermes Investigational Site
RECRUITING

Denver, North Carolina, 28037, United States
Alkermes Investigational Site
RECRUITING

Huntersville, North Carolina, 28708, United States
Alkermes Investigational Site
RECRUITING

Canton, Ohio, 44718, United States
Alkermes Investigational Site
RECRUITING

Cincinnati, Ohio, 45212, United States
Alkermes Investigational Site
RECRUITING

Cincinnati, Ohio, 45245, United States
Alkermes Investigational Site
RECRUITING

Dublin, Ohio, 43017, United States
Alkermes Investigational Site
RECRUITING

Abington, Pennsylvania, 19001, United States
Alkermes Investigational Site
RECRUITING

Wyomissing, Pennsylvania, 19610, United States
Alkermes Investigational Site
RECRUITING

Columbia, South Carolina, 29201, United States
Alkermes Investigational Site
RECRUITING

Austin, Texas, 78731, United States
Alkermes Investigational Site
RECRUITING

San Antonio, Texas, 78229, United States
Alkermes Investigational Site
RECRUITING

Sugar Land, Texas, 77478, United States
Alkermes Investigational Site
RECRUITING

Madison, Wisconsin, 53706, United States
Alkermes Investigational Site
RECRUITING

Sydney, New South Wales, 2113, Australia
Alkermes Investigational Site
RECRUITING

Bedford Park, South Australia, 5042, Australia
Alkermes Investigational Site
RECRUITING

Clayton, Victoria, 3168, Australia
Alkermes Investigational Site
RECRUITING

Bruges, Brugge, 8000, Belgium
Alkermes Investigational Site
RECRUITING

Alken, 3570, Belgium
Alkermes Investigational Site
RECRUITING

Namur, 5101, Belgium
Alkermes Investigational Site
RECRUITING

Prague, 128 21, Czechia
Alkermes Investigational Site
RECRUITING

Montpellier, Herault, 34295, France
Alkermes Investigational Site
RECRUITING

Bordeaux, 33000, France
Alkermes Investigational Site
RECRUITING

Bologna, 40139, Italy
Alkermes Investigational Site
RECRUITING

Milan, 20127, Italy
Alkermes Investigational Site
RECRUITING

Verona, 37134, Italy
Alkermes Investigational Site
RECRUITING

Zwolle, 8025, Netherlands
Alkermes Investigational Site
RECRUITING

Madrid, Madrid, 28036, Spain
Alkermes Investigational Site
RECRUITING

Barcelona, 08036, Spain
Alkermes Investigational Site
RECRUITING

Madrid, 28043, Spain
Alkermes Investigator Site
RECRUITING

Phoenix, Arizona, 85054, United States
Alkermes Investigator Site
RECRUITING

San Francisco, California, 94158, United States

Conditions

Explore the condition pages connected to this study.

IDIOPATHIC HYPERSOMNIA NARCOLEPSY TYPE 1 NARCOLEPSY TYPE 2